bioRxiv Science⌕ Search

Biology subjects

Shaw, A. Y.

Publications and source records attributed to Shaw, A. Y..

3 recordsLinked to original sources

Removing bias in sequence models of protein fitness

Unsupervised sequence models for protein fitness have emerged as powerful tools for protein design in order to engineer therapeutics and industrial enzymes, yet they are strongly biased towards potential designs that are close to their training data. This hinders their ability to generate functional sequences that are far away from natural sequences, as is often desired to design new functions. To address this problem, we introduce a de-biasing approach that enables the comparison of protein sequences across mutational depths to overcome the extant sequence similarity bias in natural sequence models. We demonstrate our methods effectiveness at improving the relative natural sequence model predictions of experimentally measured variant functions across mutational depths. Using case studies proteins with very low functional percentages further away from the wild type, we demonstrate that our method improves the recovery of top-performing variants in these sparsely functional regimes. Our method is generally applicable to any unsupervised fitness prediction model, and for any function for any protein, and can thus easily be incorporated into any computational protein design pipeline. These studies have the potential to develop more efficient and cost-effective computational methods for designing diverse functional proteins and to inform underlying experimental library design to best take advantage of machine learning capabilities.

bioinformatics↗

Deep learning prediction of enzyme optimum pH

The relationship between pH and enzyme catalytic activity, especially the optimal pH (pHopt) at which enzymes function, is critical for biotechnological applications. Hence, computational methods to predict pHopt will enhance enzyme discovery and design by facilitating accurate identification of enzymes that function optimally at specific pH levels, and by elucidating sequence-function relationships. In this study, we proposed and evaluated various machine-learning methods for predicting pHopt, conducting extensive hyperparameter optimization, and training over 11,000 model instances. Our results demonstrate that models utilizing language model embeddings markedly outperform other methods in predicting pHopt. We present EpHod, the best-performing model, to predict pHopt, making it publicly available to researchers. From sequence data, EpHod directly learns structural and biophysical features that relate to pHopt, including proximity of residues to the catalytic center and the accessibility of solvent molecules. Overall, EpHod presents a promising advancement in pHopt prediction and will potentially speed up the development of enzyme technologies.

biochemistry↗

An in silico method to assess antibody fragment polyreactivity

Antibodies are essential biological research tools and important therapeutic agents, but some exhibit non-specific binding to off-target proteins and other biomolecules. Such polyreactive antibodies compromise screening pipelines, lead to incorrect and irreproducible experimental results, and are generally intractable for clinical development. We designed a set of experiments using a diverse naive synthetic camelid antibody fragment ( nanobody) library to enable machine learning models to accurately assess polyreactivity from protein sequence (AUC > 0.8). Moreover, our models provide quantitative scoring metrics that predict the effect of amino acid substitutions on polyreactivity. We experimentally tested our models performance on three independent nanobody scaffolds, where over 90% of predicted substitutions successfully reduced polyreactivity. Importantly, the model allowed us to diminish the polyreactivity of an angiotensin II type I receptor antagonist nanobody, without compromising its pharmacological properties. We provide a companion web-server that offers a straightforward means of predicting polyreactivity and polyreactivity-reducing mutations for any given nanobody sequence.

pharmacology and toxicology↗